bio-reference labs inc (BFR:Berlin)
bio-reference labs inc (BFR) Snapshot
|
Open
€21.31
|
Previous Close
€21.16
|
|
|
Day High
€21.31
|
Day Low
€21.31
|
|
|
52 Week High
10/12/12 - €24.75
|
52 Week Low
04/16/13 - €17.88
|
|
|
Market Cap
--
|
Average Volume 10 Days
0.0
|
|
|
EPS TTM
--
|
Shares Outstanding
0.0
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
bio-reference labs inc (BFR) Related Businessweek News
No Related Businessweek News Foundbio-reference labs inc (BFR) Details
Bio-Reference Laboratories, Inc. provides clinical laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases primarily in the greater New York metropolitan area. The company offers chemical diagnostic tests, such as blood and urine analysis, blood chemistry, hematology services, serology, radio-immuno analysis, toxicology (including drug screening), pap smears, tissue pathology (biopsies), and other tissue analysis, as well as performs cancer cytogenetic testing. It primarily focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional health care services. The company also operates a clinical knowledge management service unit, which uses customer data from laboratory results, pharmaceutical data, claims data, and other data sources to provide administrative and clinical decision support systems; and a Web-based connectivity portal solution for laboratories and physicians. Bio-Reference Laboratories, Inc. provides its services directly to physicians, geneticists, hospitals, clinics, and correctional and other health facilities. The company was founded in 1981 and is headquartered in Elmwood Park, New Jersey.
bio-reference labs inc (BFR) Top Compensated Officers
bio-reference labs inc (BFR) Key Developments
Bio-Reference Laboratories Inc. reported unaudited consolidated financial results for the second quarter and six months ended April 30, 2013. For the quarter, the company reported revenues of $176,452,000, representing an increase of 17% over the $151,443,000 recorded in second quarter of fiscal 2012. Operating income was $20,709,000, an increase of 23% over $16,771,000 in second quarter of fiscal 2012. Net income after taxes was at $11,338,000, resulting in earnings per share of $0.41, up from net income after taxes of $9,306,000 and EPS of $0.33 in second quarter of fiscal 2012, increases of 22% and 24%, respectively. Income before taxes was $20,195,000 against $16,401,000 in second quarter of fiscal 2012. Six-month revenues increased to $337,709,000, an increase of 16% over the first six months of fiscal 2012 revenues of $290,236,000. Operating income was $36,468,000, an increase of 21% over fiscal 2012 six-month operating income of $30,055,000. Net income after taxes was $20,003,000 resulting in an EPS of $0.72, an increase of 20% over first six-months fiscal 2012 net income after taxes of $16,671,000, which resulted in an EPS of $0.60. Cash flow from operations was $12,832,000 down from $23,650,000 in the prior year same period. Income before taxes was $35,569,000 against $29,368,000 in the prior year same period.
Bio-Reference Laboratories Inc. Presents at William Blair & Company 33(rd) Annual Growth Stock Conference, Jun-12-2013 04:40 PM. Venue: Four Seasons Hotel, Chicago, Illinois, United States. Speakers: Marc D. Grodman, Founder, Chairman, Chief Executive Officer, President and Managing Director.
Bio-Reference Laboratories Inc., Q2 2013 Earnings Call, Jun 06, 2013

| Recently Viewed | |||
| BFR:GR | €21.31 EUR | +0.155 | |
| Company | Last | Change |
| Enzo Biochem Inc | $2.31 USD | +0.02 |
| Genomic Health Inc | $33.55 USD | -0.50 |
| LipoScience Inc | $6.61 USD | -0.10 |
| Myriad Genetics Inc | $25.88 USD | -0.56 |
| NeoGenomics Inc | $3.99 USD | -0.09 |
| View Industry Companies | ||
Industry Analysis
BFR
Industry Average
| Valuation | BFR | Industry Range |
| Price/Earnings | 17.5x |
|
| Price/Sales | 1.1x |
|
| Price/Book | 3.2x |
|
| Price/Cash Flow | 12.5x |
|
| TEV/Sales | 1.0x |
|
Post a JobJobs
- Chicago, IL | DunnhumbyusaPosted: Jun 18
- Thomasville, GA | Flowers FoodsPosted: Jun 07
- San Francisco, CA | YelpPosted: Jun 06
- San Francisco, CA | PeoplematterPosted: Jun 06
Sponsored Financial Commentaries
Sponsored Links
To contact BIO-REFERENCE LABS INC, please visit www.bioreference.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








